The doors of precision: Reenergizing psychiatric drug development with psychedelics and open access computational tools.
Daniel S. Barron, Richard A. Friedman
Sci Adv March 16, 2022 DOI: 10.1126/sciadv.abp8283 (opens in new tab) via PubMed Central
Summary
AI-generated from the abstractThe text argues that combining psychedelic compounds with open-access computational tools could revitalize psychiatric drug development, which has stagnated. It proposes that precision medicine approaches, enabled by these tools, may allow for more targeted and effective treatments. The authors suggest this integration could overcome current limitations in the field, though no empirical data or results are presented.
Study at a glance
| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Citations | 5 |
| Key finding | Argues that psychedelics and open-access computational tools can reinvigorate psychiatric drug development by enabling more precise targeting of neural circuits. |
Abstract
The doors of precision: Reenergizing psychiatric drug development with psychedelics and open access computational tools.